Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B

Summary by Helena Independent Record
SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced the completion of patient enrollment in…

37 Articles

ABC FOX MontanaABC FOX Montana
+35 Reposted by 35 other sources
Center

AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced the completion of patient enrollment in…

·Missoula, United States
Read Full Article
GeneOnline NewsGeneOnline News

AusperBio Completes Patient Enrollment for Phase II Trials of AHB-137 Targeting Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 95% of the sources are Center
95% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Helena Independent Record broke the news in Helena, United States on Friday, September 19, 2025.
Sources are mostly out of (0)

Similar News Topics

San Francisco, California icon

San Francisco, California

News
For You
SearchBlindspotLocal